access

News

Eisai plans ‘patient-proposed’ trial of cancer drug Tazverik

Eisai has reached an agreement with Japan’s National Cancer Centre to run a trial of its EZH2 inhibitor Tazverik in young people with cancers who either have no drug treatment availab

Market Access

The secret to enrolling more women in clinical research

Women are still underrepresented in clinical research.

Digital

Leave no one behind: Digital user research in rare disease

Digital solutions have the potential to bridge care gaps for rare disease patients.

News

Dismay as UK raises clawback rate on NHS drug spending

Rise in rate to 27.5% from 1st April will damage the UK economy, claim senior industry figures.

News

US states sue FDA over access to abortion pills

The complaint is asking the FDA to relax "onerous" REMS restrictions on mifepristone.

News

US braces for Texas verdict on abortion pill access

A district court decision due in Texas in the coming days could have sweeping ramifications on access to abortion pills in the US, and reverse recent moves by the Biden ad

Eisai plans ‘patient-proposed’ trial of cancer drug Tazverik

The secret to enrolling more women in clinical research

Leave no one behind: Digital user research in rare disease

Dismay as UK raises clawback rate on NHS drug spending

US states sue FDA over access to abortion pills

US braces for Texas verdict on abortion pill access

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

access

Editor's Picks